Most U.S. consumers are very interested in receiving regular messages from their health plans – if those messages are highly relevant to them and can help them stay healthier and/or save money. That’s the conclusion drawn from a new online Pollfish survey of 400 consumers conducted on behalf of RxEOB who are members of commercial and government-sponsored health plans.

Evidenced by the move to measure and reimburse providers based on the quality, as opposed to the quantity, of care delivered, the healthcare industry is shifting from a fee-for-service to an outcomes or value-based model.

Continuing its efforts to address high prescription drug costs, insurer Highmark entered into a new outcomes-based contract with Boehringer Ingelheim for Jardiance (empagliflozin), an oral medicine indicated to lower blood sugar in adults with type 2 diabetes, and also to reduce the risk of cardiovascular death in adults with type 2 diabetes who have known cardiovascular disease.

Physicians and health plan executives agree that healthcare has made little progress toward value-based care since last year, according to a survey by Quest Diagnostics.

One Drop, a digital diabetes care and self-management platform, announced a multi-part collaboration with Fitbit that will use the power of Fitbit wearable data to bring enhanced data-driven care management tools to the diabetes community.

Nearly 3 in 10 – 29 percent – of total U.S. health care payments were tied to alternative payment models in 2016, compared to 23 percent in 2015, according to a report by the Health Care Payment Learning & Action Network. The public-private partnership was launched in March 2015 to drive adoption and alignment of APMs.